| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,610,000 |
| Market
Cap: |
77.19(M) |
| Last
Volume: |
1,136,985 |
Avg
Vol: |
1,133,827 |
| 52
Week Range: |
$0.900001 - $3.22 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Media |
| Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
880,962 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gurrola Sandra M |
Vice President of Finance |
• • – |
2023-06-21 |
4 |
D |
$2.48 |
$444 |
D/D |
(179) |
928 |
|
- |
|
| Gurrola Sandra M |
Vice President of Finance |
• • – |
2023-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
438 |
1,107 |
|
- |
|
| Denny George P III |
10% Owner |
– – • |
2022-12-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
457,238 |
|
3% |
|
| Cherington Charles |
|
• • • |
2022-12-02 |
4 |
B |
$3.28 |
$858,560 |
D/D |
261,756 |
556,465 |
0.01 |
3% |
|
| Singer Nicholas Jason |
|
• • – |
2022-12-02 |
4 |
B |
$3.28 |
$929,178 |
I/I |
283,286 |
266,214 |
0.01 |
3% |
|
| Halpern John D |
10% Owner |
– – • |
2022-12-02 |
4 |
B |
$3.28 |
$1,101,818 |
I/I |
335,920 |
450,961 |
1.5 |
3% |
|
| Sidhu Roger |
Chief Medical Officer |
• • – |
2022-09-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,163 |
20,163 |
|
- |
|
| Damour Kevin |
Chief Scientific Officer |
• • – |
2022-06-28 |
4 |
D |
$0.55 |
$3,363 |
D/D |
(6,077) |
11,496 |
|
- |
|
| Damour Kevin |
Chief Scientific Officer |
• • – |
2022-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,573 |
17,573 |
|
- |
|
| Gurrola Sandra M |
Vice President of Finance |
• • – |
2022-06-21 |
4 |
D |
$0.48 |
$1,709 |
D/D |
(3,586) |
13,367 |
|
- |
|
| Gurrola Sandra M |
Vice President of Finance |
• • – |
2022-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
16,953 |
|
- |
|
| Singer Nicholas Jason |
|
– • – |
2022-06-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,095,000 |
|
- |
|
| Angel Matthew |
Interim President and CEO |
• – – |
2022-05-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,580,663 |
|
- |
|
| Angel Matthew |
Interim President and CEO |
• – – |
2022-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
909,003 |
|
- |
|
| Denny George P III |
10% Owner |
– – • |
2021-07-14 |
4 |
B |
$11.99 |
$12 |
I/I |
1 |
3 |
1.42 |
- |
|
| Denny George P III |
10% Owner |
– – • |
2021-07-09 |
4 |
B |
$14.11 |
$14 |
I/I |
1 |
2 |
1.42 |
- |
|
| Denny George P III |
10% Owner |
– – • |
2021-07-08 |
4 |
B |
$14.35 |
$14 |
I/I |
1 |
1 |
1.42 |
- |
|
| Denny George P III |
10% Owner |
– – • |
2021-07-06 |
4 |
S |
$16.06 |
$1,204,688 |
I/I |
(75,000) |
4,775,117 |
|
- |
|
| Cherington Charles |
|
• • • |
2021-06-17 |
4 |
S |
$15.74 |
$3,149,808 |
D/D |
(200,000) |
5,894,101 |
|
- |
|
| Cherington Charles |
|
• • • |
2021-06-16 |
4 |
S |
$15.73 |
$3,146,760 |
D/D |
(200,000) |
6,094,101 |
|
- |
|
| Cherington Charles |
|
• • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
92 |
5,894,193 |
|
- |
|
| Halpern Katherine H. |
10% Owner |
– – • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,776,213 |
|
- |
|
| Halpern Katherine H. |
10% Owner |
– – • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,094 |
|
- |
|
| Cherington Charles |
|
– • • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,294,101 |
|
- |
|
| Denny George P III |
|
– • • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,884,702 |
|
- |
|
232 Records found
|
|
Page 1 of 10 |
|
|
0.15 (8.48%) 
